Skin News and Research

RSS

Prostate adjustable continence therapy is a safe and effective treatment for post radical prostatectomy incontinence

Urinary incontinence after radical prostatectomy may affect 3-8% of patients and can have a significant negative impact on a patient's quality of life.

14 Jun 2006

Smokers with wrinkled faces five times at risk of serious lung disease

New research by British scientists has found that heavy wrinkles on the faces of smokers may be an early warning sign of a serious lung disease.

14 Jun 2006

Hospitals, dirty hands and the risk of disease

Thousands of patients in hospitals each year are at risk of potentially fatal infections because health care workers do not wash their hands on enough occasions.

13 Jun 2006

Microbes could represent the future of medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders.

9 Jun 2006

New football boots and toxic shock syndrome

As the World Cup kicks off, doctors in this week's British Medical Journal report an unusual condition that can develop in budding young footballers.

8 Jun 2006

Aggressive invasive treatment of heart attack patients who develop cardiogenic shock could save lives

Despite advances in treatment, people with a heart attack who survive the first hit and get to a hospital remain in danger.

7 Jun 2006

First analysis of the genes of a community of human microbes

Researchers have completed the first analysis of the genes of a community of human microbes, an accomplishment that has far-reaching implications for clinical diagnosis and treatment of many human diseases.

7 Jun 2006

Trastuzumab results promising for HER-2 positive breast cancer patients

Researchers have shown that patients who receive trastuzumab at the same time as post-chemotherapy radiation treatments for HER-2 positive breast cancer have no more risk for major side effects or complications than those who do not receive the drug.

7 Jun 2006

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006

Evidence is strong that green tea lowers the risk for a number of chronic diseases

There is a lower incidence of cardiovascular disease and cancer in Asia where people smoke heavily, which may be accounted for by high consumption of tea, particularly green tea, according to a review article published by a Yale School of Medicine researcher.

6 Jun 2006

New drug combo to cut cardiovascular disease

A major international study to test whether a new combination treatment that increases good "HDL" cholesterol prevents heart attacks and strokes will start to recruit patients later this year.

6 Jun 2006

Study shows skin rash in patients treated for liver cancer determines survival

In a study of a new chemotherapy drug for liver cancer, researchers found that the development of a skin rash correlated directly with the patient's response to treatment.

6 Jun 2006

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

People with advanced gastrointestinal stromal tumors (GIST) who take Gleevec (imatinib) for prolonged periods continue to benefit from the drug, according to a five-year study by Oregon Health & Science University Cancer Institute researchers.

6 Jun 2006

Study finds ways to improve detection of blood clots in the lung

Largest study ever conducted to assess the role of contrast-enhanced multidetector computed tomographic (CT) angiography for diagnosing pulmonary embolism.

5 Jun 2006

Humans are a cocktail of bacteria and human cells

Gene experts after studying the DNA of hundreds of different kinds of bacteria in the human gut have reached the conclusion that the human race may not be quite as human as we may think.

4 Jun 2006

Molecular pathway may contribute to age related diseases

A common molecular denominator in aging and many age-related diseases is oxidative stress.

1 Jun 2006

Promising new vaccine delivery approach

The field of vaccine development is getting a boost from new research that has identified a promising vaccine delivery approach, which in animal studies produced long-term immune protection after just one immunization.

31 May 2006

Control your diabetes for life

The prevalence of diagnosed diabetes in U.S. adults age 20 and older has risen from about 5.1 percent to 6.5 percent.

31 May 2006

Finding opens new pathways for treating or preventing autoimmune diseases

A rare genetic defect that can trigger a host of diseases from type 1 diabetes to alopecia has helped explain the imbalance of immune regulator and killer cells in autoimmune disease.

31 May 2006